Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Mol Immunol. 2013 Jan 20;54(3-4):302–308. doi: 10.1016/j.molimm.2012.12.018

Table 1.

EAE clinical signs in wild-type mice treated with PBS or mAb 1379.

CDI Disease Onset Disease Incidence
30 Days PID PBS-treated
n=9		 57.7 13.1d 100
mAb 1379-treated
n=10		 41.6* 15.4d 80
52 Days PID PBS-treated
n=8		 179 9.1d 100
mAb 1379-treated
n=9		 102* 13.8d 89

CDI = cumulative disease index, PI = post-induction of EAE.

*

Significantly different than PBS-treated controls, p<0.05.